Literature DB >> 11763417

Invasiveness in vitro and biological markers in human primary glioblastomas.

O D Laerum1, S J Nygaar, S Steine, S J Mørk, O Engebraaten, A Peraud, P Kleihues, H Ohgaki.   

Abstract

Invasion of spheroids from 20 human primary glioblastomas into precultured fetal rat brain tissue in culture has been studied and quantified. Between 30 and 98 percent of the normal brain tissue was destroyed by invading glioma cells within 4 days. The degree of invasion did not correlate with patient survival. A slightly higher invasiveness and shorter survival was seen in tumors with EGF receptor overexpression, and the opposite pattern was found for tumors with a TP53 mutation. The degree of invasiveness in vitro was far higher than would be expected from the dynamics of clinically observed tumor spread. This suggests that mechanisms suppressing invasion may be operative in the normal brain; alternatively the differences may be due to a higher permissiveness of the fetal brain tissue for invasion in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11763417     DOI: 10.1023/a:1012565503958

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

Review 1.  Histopathologic and immunohistochemical prognostic factors in malignant gliomas.

Authors:  A O Stemmer-Rachamimov; D N Louis
Journal:  Curr Opin Oncol       Date:  1997-05       Impact factor: 3.645

2.  Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo.

Authors:  R Bjerkvig; O D Laerum; O Mella
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

3.  Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.

Authors:  M Lund-Johansen; R Bjerkvig; P A Humphrey; S H Bigner; D D Bigner; O D Laerum
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

4.  Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.

Authors:  Z Tang; L Qin; X Wang; G Zhou; Y Liao; Y Weng; X Jiang; Z Lin; K Liu; S Ye
Journal:  Chin Med J (Engl)       Date:  1998-04       Impact factor: 2.628

5.  Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.

Authors:  M Marutani; H Tonoki; M Tada; M Takahashi; H Kashiwazaki; Y Hida; J Hamada; M Asaka; T Moriuchi
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

6.  Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion.

Authors:  P H Pedersen; G O Ness; O Engebraaten; R Bjerkvig; J R Lillehaug; O D Laerum
Journal:  Int J Cancer       Date:  1994-01-15       Impact factor: 7.396

7.  Interaction between rat glioma cells and normal rat brain tissue in organ culture.

Authors:  S K Steinsvåg; O D Laerum; R Bjerkvig
Journal:  J Natl Cancer Inst       Date:  1985-05       Impact factor: 13.506

Review 8.  Mutual interactions between p53 and growth factors in cancer.

Authors:  J G Asschert; E Vellenga; S De Jong; E G de Vries
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

9.  Invasion of rat neurogenic cell lines in embryonic chick heart fragments in vitro.

Authors:  L I de Ridder; O D Laerum
Journal:  J Natl Cancer Inst       Date:  1981-04       Impact factor: 13.506

10.  Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis.

Authors:  S Leenstra; E K Bijlsma; D Troost; J Oosting; A Westerveld; D A Bosch; T J Hulsebos
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  8 in total

1.  Interleukin-1 regulates the expression of sphingosine kinase 1 in glioblastoma cells.

Authors:  Barbara S Paugh; Lauren Bryan; Steven W Paugh; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Dmitri Kapitonov; Hanna Rokita; Sarah Wright; Irene Griswold-Prenner; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

2.  Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.

Authors:  Lauren Bryan; Barbara S Paugh; Dmitri Kapitonov; Katarzyna M Wilczynska; Silvina M Alvarez; Sandeep K Singh; Sheldon Milstien; Sarah Spiegel; Tomasz Kordula
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

3.  Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro.

Authors:  Jan Gliemroth; Thomas Feyerabend; Christiane Gerlach; Hans Arnold; A Jorge A Terzis
Journal:  Neurosurg Rev       Date:  2003-02-12       Impact factor: 3.042

4.  Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion.

Authors:  Xuguang Zheng; Feng Jiang; Mark Katakowski; Xuepeng Zhang; Hao Jiang; Zheng Gang Zhang; Michael Chopp
Journal:  Cancer Lett       Date:  2008-03-20       Impact factor: 8.679

5.  A coculture assay to visualize and monitor interactions between migrating glioma cells and nerve fibers.

Authors:  Patrick Oellers; Maurice Schallenberg; Tobias Stupp; Petar Charalambous; Volker Senner; Werner Paulus; Solon Thanos
Journal:  Nat Protoc       Date:  2009-05-21       Impact factor: 13.491

6.  Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma.

Authors:  Michael D Jenkinson; Trevor S Smith; Brian Haylock; David Husband; Aditya Shenoy; Sobhan Vinjamuri; Carol Walker; Denis Pietronigro; Peter C Warnke
Journal:  J Neurooncol       Date:  2010-01-10       Impact factor: 4.130

7.  Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.

Authors:  Xu Wang; Zhaohao Wang; Yu Zhang; Yan Wang; Hao Zhang; Shao Xie; Peng Xie; Rutong Yu; Xiuping Zhou
Journal:  Cell Prolif       Date:  2019-05-16       Impact factor: 6.831

8.  MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.

Authors:  Yong Lu; Michael Chopp; Xuguang Zheng; Mark Katakowski; Benjamin Buller; Feng Jiang
Journal:  Oncol Rep       Date:  2012-10-17       Impact factor: 3.906

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.